EUVIMEDEUVIMED entdecken
Crossref

Effects of Integrin‐Linked Kinase Silencing Combined With Trichostatin A on Cancer Stem Cells

Yulu Wu iD, Zhiyong Guo, Zhangao Li, Chenchen Cai, Jiyuan Liu, Xiufa Tang, Lin Que

Oral Diseases · 2025

DOI: 10.1111/odi.15377 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oral Diseases, 2025. Verfasst von Yulu Wu und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases, West China Hospital of…. Hauptthemen laut MEDLINE: Neoplastic Stem Cells, Hydroxamic Acids, Mouth Neoplasms, Carcinoma, Squamous Cell. Die Arbeit nennt 28 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science and Technology Department of Sichuan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Oral squamous cell carcinoma (OSCC) is characterized by high invasiveness and metastasis, with cancer stem cells (CSCs) playing a central role in tumor progression. This study investigates the effects of integrin‐linked kinase (ILK) silencing and trichostatin A (TSA) treatment on CSCs, assessing their potential to diminish CSC properties and inhibit OSCC progression. Methods and Materials CSCs were enriched and isolated from primary OSCC samples and Tca8113 cell line and MOC1 cell line using side population (SP) analysis, with their characteristics and the therapeutic impact of treatments assessed through assays such as MTT, wound healing, cell invasion, cell cycle, and apoptosis.

Results

Higher SP cell content correlated significantly with poor pathological classification, metastasis, and recurrence. Treated CSCs showed reduced proliferation, migration, and invasion, along with increased apoptosis. In vivo experiments demonstrated that the combined treatment substantially reduced tumor growth.

Conclusion

The study confirms the efficacy of targeting CSCs with ILK silencing and TSA treatment in OSCC, suggesting a promising strategy for CSC‐directed therapies that merit further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplastic Stem CellsHydroxamic AcidsMouth NeoplasmsCarcinoma, Squamous CellProtein Serine-Threonine KinasesHumansApoptosisCell Line, TumorCell ProliferationCell MovementAnimalsGene SilencingFemaleMaleMiddle AgedMiceMice, NudeCell CycleNeoplasm InvasivenessAgedScaffold Protein ILK

Stichwörter der Autor:innen

CSCILKOSCCTSAcell isolationoral oncologyside population

Substanzen

Hydroxamic AcidsProtein Serine-Threonine KinasesScaffold Protein ILKtrichostatin A

Autor:innen und Institutionen

  • State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, China.
  • Department of Oral and Maxillofacial Surgery, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, China.

ORCID-Profile: Yulu Wu

Förderung

  • National Natural Science Foundation of China
  • Science and Technology Department of Sichuan Province

Zitieren

APA

Wu, Y., Guo, Z., Li, Z., Cai, C., Liu, J., Tang, X., & Que, L. (2025). Effects of Integrin‐Linked Kinase Silencing Combined With Trichostatin A on Cancer Stem Cells. Oral Diseases. https://doi.org/10.1111/odi.15377

Vancouver

Wu Y, Guo Z, Li Z, Cai C, Liu J, Tang X, et al. Effects of Integrin‐Linked Kinase Silencing Combined With Trichostatin A on Cancer Stem Cells. Oral Diseases. 2025. doi:10.1111/odi.15377

BibTeX
@article{Wu2025,
  author = {Wu, Yulu and Guo, Zhiyong and Li, Zhangao and Cai, Chenchen and Liu, Jiyuan and Tang, Xiufa and Que, Lin},
  title = {Effects of Integrin‐Linked Kinase Silencing Combined With Trichostatin A on Cancer Stem Cells},
  journal = {Oral Diseases},
  year = {2025},
  doi = {10.1111/odi.15377}
}
Kostenlos starten →